Azioni W WORL

Azioni

Mercato chiuso - OTC Markets Altri mercati azionari 02:10:00 12/12/2023			Variaz. 5gg	Var. 1 gen.
0,8 ^USD	-.--%		-.--%	-.--%

Durata

Periodo

Stile

Pharmos Corp. Designates Eric Fangmann as Acting President and Acting Chief Financial Officer	02/01/13
Pharmos Corp. Announces Management Changes	17/10/12
Pharmos Corp. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2012	30/07/12
Pharmos Corp. Announces Successfully Completion of Proof-Of-Concept Clinical Trial Using its Compound Levotofisopam to Treat Patients with Hyperuricemia and Gout	17/05/12
Pharmos Corp. Announces Unaudited Consolidated Financial Results for the First Quarter Ended March 31, 2012	16/04/12